Balaji Amines (BALAMINES)₹1,797+1.10%Specialty Chemicals
In the Jun 2026 quarter (consolidated), Balaji Amines reported sales of ₹457 Cr, up 27.3% from Jun 2025, and net profit of ₹78.28 Cr, up 110.8% year on year. For the year to Mar 2026, sales were ₹1,423 Cr and net profit ₹170 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 383 | 384 | 415 | 386 | 348 | 314 | 354 | 359 | 342 | 332 | 396 | 457 |
| Expenses | 328 | 310 | 317 | 320 | 287 | 268 | 294 | 305 | 282 | 276 | 302 | 341 |
| Operating Profit | 53.89 | 73.89 | 97.87 | 65.93 | 60.93 | 45.91 | 59.90 | 54.92 | 59.90 | 56.88 | 93.80 | 116 |
| OPM % | 14.1% | 19.1% | 24.0% | 17.1% | 17.1% | 15.1% | 17.1% | 15.0% | 18.1% | 17.0% | 24.1% | 25.1% |
| Other Income | 7.01 | 8.01 | 8.99 | 7.99 | 8.99 | 7.99 | 8.01 | 9.01 | 6.99 | 4.99 | 8.01 | 6.01 |
| Interest | 2.01 | 2.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 2.01 | 1.01 |
| Depreciation | 10.97 | 10.98 | 11.97 | 11.97 | 11.97 | 11.98 | 12.96 | 13.97 | 13.97 | 13.96 | 13.97 | 13.97 |
| Profit before tax | 48.04 | 70.06 | 93.11 | 62.12 | 57.04 | 41.07 | 54.06 | 49.03 | 52.02 | 46.09 | 86.11 | 106 |
| Tax % | 24.1% | 21.0% | 22.1% | 26.1% | 27.1% | 24.1% | 25.1% | 25.1% | 28.0% | 33.1% | 25.1% | 26.1% |
| Net Profit | 36.16 | 56.21 | 72.32 | 46.14 | 41.14 | 31.09 | 40.12 | 37.14 | 37.11 | 31.09 | 65.20 | 78.28 |
| EPS (Rs) | 10.70 | 15.22 | 20.95 | 13.33 | 12.62 | 10.22 | 12.34 | 11.71 | 10.64 | 9.69 | 19.49 | 23.08 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 642 | 670 | 862 | 943 | 939 | 1,313 | 2,322 | 2,355 | 1,637 | 1,393 | 1,423 | 1,528 |
| Expenses | 516 | 520 | 678 | 750 | 757 | 938 | 1,696 | 1,743 | 1,313 | 1,161 | 1,158 | 1,201 |
| Operating Profit | 127 | 149 | 182 | 193 | 181 | 373 | 622 | 609 | 324 | 232 | 264 | 326 |
| OPM % | 20.1% | 22.0% | 21.0% | 21.1% | 19.0% | 29.1% | 27.1% | 26.0% | 20.0% | 17.1% | 19.1% | 21.4% |
| Other Income | 3.01 | 8.99 | 11.99 | 4.01 | 4.99 | 5.99 | 15.01 | 15.01 | 29.99 | 33.01 | 29.01 | 26.00 |
| Interest | 22.01 | 13.01 | 9.01 | 13.01 | 23.01 | 18.01 | 17.02 | 12.02 | 6.01 | 4.01 | 5.01 | 6.04 |
| Depreciation | 18.95 | 19.93 | 18.95 | 19.94 | 31.90 | 33.92 | 41.89 | 45.89 | 44.88 | 47.84 | 55.88 | 55.87 |
| Profit before tax | 88.12 | 126 | 166 | 165 | 131 | 327 | 579 | 568 | 302 | 213 | 232 | 290 |
| Tax % | 34.1% | 34.1% | 32.1% | 29.0% | 26.0% | 25.1% | 28.1% | 28.0% | 23.1% | 26.1% | 27.1% | — |
| Exceptional items | 0.00 | 2.01 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 2.01 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 58.20 | 82.33 | 113 | 117 | 97.40 | 244 | 419 | 407 | 233 | 159 | 170 | 212 |
| EPS (Rs) | 17.74 | 25.37 | 34.85 | 36.21 | 32.27 | 73.38 | 113.50 | 100.33 | 63.08 | 48.53 | 51.54 | 62.90 |
| Dividend payout % | 11.1% | 9.1% | 7.1% | 8.1% | 10.0% | 5.0% | 5.0% | 10.1% | 17.1% | 23.1% | 21.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.01 | 6.01 | 5.98 | 5.99 | 6.00 | 5.99 | 5.98 | 5.99 | 5.99 | 5.98 | 5.99 | 5.99 |
| Reserves | 222 | 275 | 358 | 462 | 570 | 654 | 891 | 1,248 | 1,553 | 1,722 | 1,845 | 1,978 |
| Borrowings | 256 | 173 | 105 | 152 | 227 | 260 | 127 | 101 | 57.91 | 19.96 | 10.98 | 133 |
| Other Liabilities | 140 | 153 | 169 | 230 | 245 | 196 | 290 | 397 | 353 | 407 | 397 | 633 |
| Total Liabilities | 625 | 607 | 637 | 850 | 1,049 | 1,116 | 1,314 | 1,751 | 1,969 | 2,155 | 2,259 | 2,751 |
| Fixed Assets | 342 | 342 | 326 | 317 | 321 | 575 | 545 | 683 | 782 | 899 | 1,007 | 1,047 |
| CWIP | 3.01 | 16.02 | 25.05 | 123 | 270 | 46.04 | 173 | 141 | 113 | 205 | 238 | 512 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 47.86 | 0.00 | 0.00 | 72.78 | 0.00 | 0.00 | 0.00 |
| Other Assets | 279 | 249 | 285 | 410 | 459 | 447 | 596 | 927 | 1,000 | 1,051 | 1,014 | 1,192 |
| Inventories | 112 | 77.78 | 98.73 | 88.67 | 162 | 109 | 110 | 221 | 302 | 286 | 273 | 246 |
| Trade receivables | 119 | 124 | 124 | 173 | 167 | 207 | 306 | 588 | 378 | 319 | 275 | 346 |
| Cash & equivalents | 7.01 | 9.02 | 3.01 | 24.02 | 20.02 | 9.01 | 20.03 | 52.08 | 236 | 340 | 354 | 271 |
| Total Assets | 625 | 607 | 637 | 850 | 1,049 | 1,116 | 1,314 | 1,751 | 1,969 | 2,155 | 2,259 | 2,751 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 56.01 | 84.99 | 60.01 | 140 | 93.96 | 144 | 110 | 220 | 354 | 334 | 255 | 184 |
| Cash from investing activity | −4.01 | −29.02 | −10.01 | −135 | −119 | −130 | −61.99 | −147 | −210 | −274 | −139 | −344 |
| Cash from financing activity | −54.88 | −53.85 | −54.88 | 15.97 | 20.94 | −25.95 | −36.91 | −56.85 | −80.78 | −74.84 | −48.87 | 84.84 |
| Net cash flow | −2.99 | 1.99 | −4.98 | 20.91 | −3.98 | −11.95 | 10.95 | 15.94 | 62.78 | −14.94 | 67.75 | −74.67 |
| Capex | 7.98 | 31.96 | 12.99 | 111 | 170 | 61.91 | 132 | 148 | 120 | 253 | 187 | 369 |
| Free cash flow | 48.04 | 52.99 | 47.02 | 32.01 | −75.01 | 83.10 | −21.02 | 72.08 | 234 | 82.09 | 68.98 | −186 |
| CFO / OP % | 65.1% | 77.1% | 58.1% | 101.1% | 74.1% | 108.0% | 40.1% | 56.1% | 81.1% | 123.1% | 128.1% | 82.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 72 | 72 | 69 | 74 | 66 | 82 | 86 | 94 | 60 | 72 | 73 | 90 |
| Inventory days | 114 | 80 | 106 | 70 | 116 | 77 | 64 | 66 | 89 | 116 | 128 | 113 |
| Days payable | 48 | 58 | 55 | 56 | 60 | 42 | 44 | 54 | 18 | 31 | 32 | 39 |
| Cash conversion cycle | 137 | 94 | 120 | 88 | 121 | 117 | 105 | 106 | 130 | 157 | 169 | 164 |
| Working capital days | 6 | 11 | 41 | 30 | 46 | 54 | 87 | 87 | 88 | 113 | 119 | 68 |
| ROCE % | 18.0% | 23.0% | 30.0% | 32.0% | 24.0% | 18.1% | 35.0% | 49.0% | 36.0% | 17.0% | 11.1% | 11.0% |
For the Jun 2026 quarter, Balaji Amines reported sales of ₹457 Cr, up 27.3% year on year and net profit of ₹78.28 Cr, up 110.8% year on year. The operating margin was 25.1%.
Balaji Amines' sales for the year to Mar 2026 were ₹1,423 Cr; over the last twelve months they were ₹1,528 Cr.
Net profit for the year to Mar 2026 was ₹170 Cr, and ₹212 Cr over the last twelve months. Earnings per share over the same trailing period were ₹62.90.
Balaji Amines reported borrowings of ₹133 Cr at Mar 2026, against cash and equivalents of ₹271 Cr.
Cash from operations was ₹184 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹186 Cr.